SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-19-047697
Filing Date
2019-08-29
Accepted
2019-08-29 16:16:45
Documents
2
Period of Report
2019-08-28

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1643
2 POA DOCUMENT poa.txt EX-24.3_870509 4808
  Complete submission text file 0001209191-19-047697.txt   7809
Mailing Address 2801 GATEWAY DRIVE SUITE 150 IRVING TX 75063
Business Address 2801 GATEWAY DRIVE SUITE 150 IRVING TX 75063 972-865-2206
REATA PHARMACEUTICALS INC (Issuer) CIK: 0001358762 (see all company filings)

IRS No.: 113651945 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address C/O PHARMACYCLICS, INC. 995 EAST ARQUES AVE SUNNYVALE CA 94085
Business Address
Soni Manmeet Singh (Reporting) CIK: 0001569769 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37785 | Film No.: 191066577